Glycointeractions in bacterial pathogenesis

Nature Reviews Microbiology

Volumn 16, Issue 7, 2018, Pages 440-452

  Poole, Jessica ^a   Day, Christopher J ^a   Von Itzstein, Mark ^a   Paton, James C ^b   Jennings, Michael P ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL TOXIN; GLYCAN; LECTIN; M PROTEIN; PNEUMOLYSIN; POLYSACCHARIDE;

BABA GENE; BACTERIAL GENE; BACTERIAL PATHOGENESIS; BACTERIUM ADHERENCE; CHEMICAL INTERACTION; COMPLEMENT RECEPTOR 3 GENE; GLYCOINTERACTION; HELICOBACTER PYLORI; IMMUNE EVASION; LABA GENE; NEISSERIA GONORRHOEAE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; REVIEW; SABA GENE; STREPTOCOCCUS PYOGENES; BACTERIUM; GLYCOSYLATION; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADHESINS, BACTERIAL; BACTERIA; BACTERIAL ADHESION; GLYCOSYLATION; HUMANS; POLYSACCHARIDES;

EID: 85045752370     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/s41579-018-0007-2     Document Type: Review

References (165)

1. Ghazarian, H., Idoni, B. &Oppenheimer, S. B. A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem. 113, 236-247 (2011)
2. Moremen, K. W., Tiemeyer, M. &Nairn, A. V. Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 13, 448-462 (2012)
3. Semchenko, E. A. et al. Structural heterogeneity of terminal glycans in Campylobacter jejuni lipooligosaccharides. PLoS ONE 7, e40920 (2012)
4. Tao, S. C. et al. Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology 18, 761-769 (2008)
5. Tateno, H. et al. Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J. Biol. Chem. 286, 20345-20353 (2011)
6. Stowell, S. R. et al. Microbial glycan microarrays define key features of host-microbial interactions. Nat. Chem. Biol. 10, 470-476 (2014). This article describes the development and testing of the first bacteria-focused glycan array, enabling the analysis of how the adaptive and non-adaptive immune responses react to surface glycans
7. Waespy, M. et al. Carbohydrate recognition specificity of trans-sialidase lectin domain from Trypanosoma congolense. PLoS Neglected Trop. Dis. 9, e0004120 (2015)
8. Naughton, J. A. et al. Divergent mechanisms of interaction of Helicobacter pylori and Campylobacter jejuni with mucus and mucins. Infect. Immun. 81, 2838-2850 (2013)
9. Carlin, A. F. et al. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113, 3333-3336 (2009)
10. Secundino, I. et al. Host and pathogen hyaluronan signal through human siglec-9 to suppress neutrophil activation. J. Mol. Med. 94, 219-233 (2016). This article was the first report of a non-sialic acid interaction with a Siglec protein, providing a new role for bacterial glycosaminoglycan structures and identifying a novel mechanism of interactions with important immunomodulatory proteins
11. Oliveira, D. M. P. et al. Blood group antigen recognition via the group a Streptococcal M protein mediates host colonization. mBio 8, e02237 (2017)
12. Ilver, D. et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279, 373-377 (1998)
13. Mahdavi, J. et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297, 573-578 (2002)
14. Rossez, Y. et al. The lacdiNAc-specific adhesin LabA mediates adhesion of Helicobacter pylori to human gastric mucosa. J. Infect. Dis. 210, 1286-1295 (2014)
15. Sokurenko, E. V. et al. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc. Natl Acad. Sci. USA 95, 8922-8926 (1998)
16. King, S. J. Pneumococcal modification of host sugars: a major contributor to colonization of the human airway? Mol. Oral Microbiol. 25, 15-24 (2010)
17. Johnston, J. W. et al. Regulation of sialic acid transport and catabolism in Haemophilus influenzae. Mol. Microbiol. 66, 26-39 (2007)
18. Byres, E. et al. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 456, 648-652 (2008). This article identifies the glycan target of the SubAB toxin of E. coli as a non-human glycosylation that is incorporated after dietary intake
19. Deng, L. et al. Host adaptation of a bacterial toxin from the human pathogen Salmonella Typhi. Cell 159, 1290-1299 (2014)
20. Shewell, L. K. et al. The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity. Proc. Natl Acad. Sci. USA 111, E5312-E5320 (2014)
21. Spaulding, C. N. et al. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist. Nature 546, 528-532 (2017)
22. Gupta, K., Hooton, T. M. &Stamm, W. E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann. Intern. Med. 135, 41-50 (2001)
23. Sanchez, G. V., Master, R. N., Karlowsky, J. A. &Bordon, J. M. In Vitro antimicrobial resistance of urinary Escherichia coli isolates among US outpatients from 2000 to 2010. Antimicrob. Agents Chemother. 56, 2181-2183 (2012)
24. Roberts, J. A. et al. The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc. Natl Acad. Sci. USA 91, 11889-11893 (1994)
25. Cusumano, C. K. et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci. Transl. Med. 3, 109ra115 (2011)
26. Guiton, P. S. et al. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice. Antimicrob. Agents Chemother. 56, 4738-4745 (2012)
27. Klein, T. et al. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation. J. Med. Chem. 53, 8627-8641 (2010)
28. Totsika, M. et al. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. J. Infect. Dis. 208, 921-928 (2013)
29. Hatakeyama, M. A. Sour relationship between BabA and Lewis b. Cell Host Microbe 21, 318-320 (2017)
30. Dunne, C., Dolan, B. &Clyne, M. Factors that mediate colonization of the human stomach by Helicobacter pylori. World J. Gastroenterol. 20, 5610-5624 (2014)
31. Magalhaes, A. et al. Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways. Biochim. Biophys. Acta 1852, 1928-1939 (2015)
32. Bugaytsova, J. A. et al. Helicobacter pylori adapts to chronic infection and gastric disease via pH-responsive BabA-mediated adherence. Cell Host Microbe 21, 376-389 (2017)
33. Ogata, M., Araki, K. &Ogata, T. An electron microscopic study of Helicobacter pylori in the surface mucous gel layer. Histol Histopathol 13, 347-358 (1998)
34. Fischetti, V. A. Streptococcal M protein: molecular design and biological behavior. Clin. Microbiol. Rev. 2, 285-314 (1989)
35. Frick, I. M., Schmidtchen, A. &Sjobring, U. Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells. Eur. J. Biochem. 270, 2303-2311 (2003)
36. Maamary, P. G. et al. Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. FASEB J. 26, 4675-4684 (2012)
37. Everest-Dass, A. V. et al. Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology 22, 1465-1479 (2012)
38. van Kooyk, Y. &Geijtenbeek, T. B. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3, 697-709 (2003)
39. Xu, J. et al. Mannose-binding lectin inhibits the motility of pathogenic Salmonella by affecting the driving forces of motility and the chemotactic response. PLoS ONE 11, e0154165 (2016)
40. Edwards, J. L. &Apicella, M. A. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin. Microbiol. Rev. 17, 965-981 (2004)
41. Harvey, H. A., Jennings, M. P., Campbell, C. A., Williams, R. &Apicella, M. A. Receptor-mediated endocytosis of Neisseria gonorrhoeae into primary human urethral epithelial cells: the role of the asialoglycoprotein receptor. Mol. Microbiol. 42, 659-672 (2001)
42. Patel, P. et al. Shared antigenicity and immunogenicity of type 4 pilins expressed by Pseudomonas aeruginosa, Moraxella bovis, Neisseria gonorrhoaea, Dichelobacter nodosus, and Vibrio cholerae. Infect. Immun. 59, 4674-4676 (1991)
43. Jennings, M. P. et al. Identification of a novel gene involved in pilin glycosylation in Neisseria meningitidis. Mol. Microbiol. 29, 975-984 (1998)
44. Banerjee, A. et al. Implications of phase variation of a gene (pgtA) encoding a pilin galactosyl transferase in gonococcal pathogenesis. J. Exp. Med. 196, 147-162 (2002)
45. Hegge, F. T. et al. Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili. Proc. Natl Acad. Sci. USA 101, 10798-10803 (2004)
46. Power, P. M. et al. Genetic characterization of pilin glycosylation in Neisseria meningitidis. Microbiology 146, 967-979 (2000)
47. Hartley, M. D. et al. Biochemical characterization of the O-linked glycosylation pathway in Neisseria gonorrhoeae responsible for biosynthesis of protein glycans containing N,N-diacetylbacillosamine. Biochemistry 50, 4936-4948 (2011)
48. Jennings, M. P., Jen, F. E., Roddam, L. F., Apicella, M. A. &Edwards, J. L. Neisseria gonorrhoeae pilin glycan contributes to CR3 activation during challenge of primary cervical epithelial cells. Cell. Microbiol. 13, 885-896 (2011)
49. Edwards, J. L., Brown, E. J., Ault, K. A. &Apicella, M. A. The role of complement receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia. Cell. Microbiol. 3, 611-622 (2001)
50. Wessels, M. R., Moses, A. E., Goldberg, J. B. &DiCesare, T. J. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl Acad. Sci. USA 88, 8317-8321 (1991)
51. Schommer, N. N., Muto, J., Nizet, V. &Gallo, R. L. Hyaluronan breakdown contributes to immune defense against group A Streptococcus. J. Biol. Chem. 289, 26914-26921 (2014)
52. Jiang, D., Liang, J. &Noble, P. W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23, 435-461 (2007)
53. Crocker, P. R., Paulson, J. C. &Varki, A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7, 255-266 (2007)
54. Varki, A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 446, 1023-1029 (2007)
55. Chang, Y. C. &Nizet, V. The interplay between Siglecs and sialylated pathogens. Glycobiology 24, 818-825 (2014)
56. Cao, H. A. &Crocker, P. R. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology 132, 18-26 (2011)
57. Lewis, A. L., Nizet, V. &Varki, A. Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc. Natl Acad. Sci. USA 101, 11123-11128 (2004)
58. Carlin, A. F., Lewis, A. L., Varki, A. &Nizet, V. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes. J. Bacteriol. 189, 1231-1237 (2007)
59. Serruto, D. et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc. Natl Acad. Sci. USA 107, 3770-3775 (2010)
60. Stephens, D. S., Greenwood, B. &Brandtzaeg, P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369, 2196-2210 (2007)
61. Jodar, L., Feavers, I. M., Salisbury, D. &Granoff, D. M. Development of vaccines against meningococcal disease. Lancet 359, 1499-1508 (2002)
62. Uria, M. J. et al. A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J. Exp. Med. 205, 1423-1434 (2008). This article describes that overproduction of a capsular polysaccharide can provide protection against host immune responses, even when the immune response is directed to the capsular polysaccharide
63. Goldschneider, I., Gotschlich, E. C. &Artenstein, M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129, 1307-1326 (1969)
64. Richmond, P. et al. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J. Infect. Dis. 179, 1569-1572 (1999)
65. Figueroa, J. E. &Densen, P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4, 359-395 (1991)
66. Jarvis, G. A. &Vedros, N. A. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55, 174-180 (1987)
67. Marques, M. B., Kasper, D. L., Pangburn, M. K. &Wessels, M. R. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60, 3986-3993 (1992)
68. Pluschke, G., Mayden, J., Achtman, M. &Levine, R. P. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing. Infect. Immun. 42, 907-913 (1983)
69. Nothaft, H. &Szymanski, C. M. Protein glycosylation in bacteria: sweeter than ever. Nat. Rev. Microbiol. 8, 765-778 (2010)
70. Parge, H. E. et al. Structure of the fibre-forming protein pilin at 2.6 A resolution. Nature 378, 32-38 (1995)
71. Stimson, E. et al. Meningococcal pilin: a glycoprotein substituted with digalactosyl 2,4-diacetamido-2,4, 6-trideoxyhexose. Mol. Microbiol. 17, 1201-1214 (1995)
72. Szymanski, C. M., Yao, R., Ewing, C. P., Trust, T. J. &Guerry, P. Evidence for a system of general protein glycosylation in Campylobacter jejuni. Mol. Microbiol. 32, 1022-1030 (1999)
73. Young, N. M. et al. Structure of the N-linked glycan present on multiple glycoproteins in the Gram-negative bacterium. Campylobacter jejuni. J. Biol. Chem. 277, 42530-42539 (2002)
74. Scott, N. E. et al. Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni. Mol. Cell Proteomics 10, M000031-MCP201 (2011)
75. Szymanski, C. M., Burr, D. H. &Guerry, P. Campylobacter protein glycosylation affects host cell interactions. Infect. Immun. 70, 2242-2244 (2002)
76. Hendrixson, D. R. &DiRita, V. J. Identification of Campylobacter jejuni genes involved in commensal colonization of the chick gastrointestinal tract. Mol. Microbiol. 52, 471-484 (2004)
77. Alemka, A., Nothaft, H., Zheng, J. &Szymanski, C. M. N-Glycosylation of Campylobacter jejuni surface proteins promotes bacterial fitness. Infect. Immun. 81, 1674-1682 (2013)
78. Grass, S. et al. The Haemophilus influenzae HMW1 adhesin is glycosylated in a process that requires HMW1C and phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthesis. Mol. Microbiol. 48, 737-751 (2003)
79. Gross, J. et al. The Haemophilus influenzae HMW1 adhesin is a glycoprotein with an unusual N-linked carbohydrate modification. J. Biol. Chem. 283, 26010-26015 (2008)
80. Hanuszkiewicz, A. et al. Identification of the flagellin glycosylation system in Burkholderia cenocepacia and the contribution of glycosylated flagellin to evasion of human innate immune responses. J. Biol. Chem. 289, 19231-19244 (2014)
81. Juge, N., Tailford, L. &Owen, C. D. Sialidases from gut bacteria: a mini-review. Biochem. Soc. Trans. 44, 166-175 (2016)
82. Kim, S., Oh, D. B., Kang, H. A. &Kwon, O. Features and applications of bacterial sialidases. Appl. Microbiol. Biotechnol. 91, 1-15 (2011)
83. Moran, A. P., Prendergast, M. M. &Appelmelk, B. J. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16, 105-115 (1996)
84. Manco, S. et al. Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect. Immun. 74, 4014-4020 (2006)
85. Xu, G. et al. Three Streptococcus pneumoniae sialidases: three different products. J. Am. Chem. Soc. 133, 1718-1721 (2011)
86. Morris, D. E., Cleary, D. W. &Clarke, S. C. Secondary bacterial infections associated with Influenza pandemics. Front. Microbiol. 8, 1041 (2017)
87. Nita-Lazar, M. et al. Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding. Mol. Immunol. 65, 1-16 (2015)
88. Wren, J. T. et al. Pneumococcal Neuraminidase A (NanA) promotes biofilm formation and synergizes with Influenza A virus in nasal colonization and middle ear infection. Infect. Immun. 85, e01044-16 (2017)
89. Bohlmann, L. et al. Functional and structural characterization of a heparanase. Nat. Chem. Biol. 11, 955-957 (2015)
90. Gao, X. et al. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-kappaB activation. Cell Host Microbe 13, 87-99 (2013)
91. Wong, A. R. et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol. Microbiol. 80, 1420-1438 (2011)
92. Pearson, J. S. et al. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 501, 247-251 (2013). This article identifies a novel host modification process that enables EPEC to inhibit infectioninduced apoptosis of host cells
93. Kulkarni, A. A., Weiss, A. A. &Iyer, S. S. Glycan-based high-affinity ligands for toxins and pathogen receptors. Med. Res. Rev. 30, 327-393 (2010). This is an excellent review on interactions between glycans and bacterial toxins
94. Sandvig, K. &van Deurs, B. Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol. 18, 1-24 (2002)
95. Paton, J. C. &Paton, A. W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11, 450-479 (1998)
96. Schiavo, G. &van der Goot, F. G. The bacterial toxin toolkit. Nat. Rev. Mol. Cell Biol. 2, 530-537 (2001)
97. Paton, A. W., Srimanote, P., Talbot, U. M., Wang, H. &Paton, J. C. A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli. J. Exp. Med. 200, 35-46 (2004)
98. Ng, P. S. et al. Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors. Nat. Commun. 5, 5750 (2014). This article provides an excellent example of using saturation transfer difference NMR for glycointeractomics using whole virus with this technique
99. Peri, S., Kulkarni, A., Feyertag, F., Berninsone, P. M. &Alvarez-Ponce, D. Phylogenetic distribution of CMPNeu5Ac Hydroxylase (CMAH), the enzyme synthetizing the proinflammatory human Xenoantigen Neu5Gc. Genome Biol. Evol. 10, 207-219 (2018)
100. Varki, A. Multiple changes in sialic acid biology during human evolution. Glycoconj J. 26, 231-245 (2009)
101. Bardor, M., Nguyen, D. H., Diaz, S. &Varki, A. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J. Biol. Chem. 280, 4228-4237 (2005)
102. Tangvoranuntakul, P. et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc. Natl Acad. Sci. USA 100, 12045-12050 (2003)
103. Parry, C. M., Hien, T. T., Dougan, G., White, N. J. &Farrar, J. J. Typhoid fever. N. Engl. J. Med. 347, 1770-1782 (2002)
104. Raffatellu, M., Wilson, R. P., Winter, S. E. &Baumler, A. J. Clinical pathogenesis of typhoid fever. J. Infect. Dev. Ctries 2, 260-266 (2008)
105. Song, J., Gao, X. &Galan, J. E. Structure and function of the Salmonella Typhi chimaeric A(2)B(5) typhoid toxin. Nature 499, 350-354 (2013)
106. Paton, J. C., Andrew, P. W., Boulnois, G. J. &Mitchell, T. J. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu. Rev. Microbiol. 47, 89-115 (1993)
107. Ramachandran, R., Tweten, R. K. &Johnson, A. E. Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit beta-strand alignment. Nat. Struct. Mol. Biol. 11, 697-705 (2004)
108. Blixt, O. et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl Acad. Sci. USA 101, 17033-17038 (2004)
109. Flannery, A., Gerlach, J. Q., Joshi, L. &Kilcoyne, M. Assessing bacterial interactions using carbohydratebased microarrays. Microarrays 4, 690-713 (2015)
110. Song, X., Heimburg-Molinaro, J., Smith, D. F. &Cummings, R. D. Glycan microarrays of fluorescentlytagged natural glycans. Glycoconj J. 32, 465-473 (2015)
111. Disney, M. D. &Seeberger, P. H. The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens. Chem. Biol. 11, 1701-1707 (2004)
112. Wang, D., Liu, S., Trummer, B. J., Deng, C. &Wang, A. Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells. Nat. Biotechnol. 20, 275-281 (2002)
113. Batista, B. S., Eng, W. S., Pilobello, K. T., Hendricks-Munoz, K. D. &Mahal, L. K. Identification of a conserved glycan signature for microvesicles. J. Proteome Res. 10, 4624-4633 (2011)
114. Ribeiro, J. P. &Mahal, L. K. Dot by dot: analyzing the glycome using lectin microarrays. Curr. Opin. Chem. Biol. 17, 827-831 (2013)
115. Ekins, R. P. Multi-analyte immunoassay. J. Pharm. Biomed. Anal. 7, 155-168 (1989)
116. Day, C. J. et al. Glycan:glycan interactions: high affinity biomolecular interactions that can mediate binding of pathogenic bacteria to host cells. Proc. Natl Acad. Sci. USA 112, E7266-E7275 (2015). This article describes the identification of wide-ranging glycan-glycan interactions between four different pathogens and host sugars
117. Mubaiwa, T. D. et al. The glycointeractome of serogroup B Neisseria meningitidis strain MC58. Sci. Rep. 7, 5693 (2017). This article provides an excellent example of glycointeractomics work flow, using whole bacteria, mutants and purified surface factors to identify the glycan-interacting features of N. meningitidis
118. Haselhorst, T. et al. Recognition of the GM3 ganglioside glycan by Rhesus rotavirus particles. Angew. Chem. Int. Ed Engl. 50, 1055-1058 (2011)
119. Kalograiaki, I. et al. Combined bacteria microarray and quartz crystal microbalance approach for exploring glycosignatures of nontypeable Haemophilus influenzae and recognition by host lectins. Anal. Chem. 88, 5950-5957 (2016)
120. Lieth, C.-W., Lutteke, T. &Frank, M. Bioinformatics for glycobiology and glycomics: an introduction (Wiley-Blackwell, 2009)
121. Porter, A. et al. A motif-based analysis of glycan array data to determine the specificities of glycan-binding proteins. Glycobiology 20, 369-380 (2010)
122. Krishnamoorthy, L. &Mahal, L. K. Glycomic analysis: an array of technologies. ACS Chem. Biol. 4, 715-732 (2009)
123. Hsu, K. L., Pilobello, K. T. &Mahal, L. K. Analyzing the dynamic bacterial glycome with a lectin microarray approach. Nat. Chem. Biol. 2, 153-157 (2006)
124. Oyelaran, O. &Gildersleeve, J. C. Glycan arrays: recent advances and future challenges. Curr. Opin. Chem. Biol. 13, 406-413 (2009)
125. Heimburg-Molinaro, J., Song, X., Smith, D. F. &Cummings, R. D. Preparation and analysis of glycan microarrays. Curr. Protoc. Protein Sci. https:// doi.org/10.1002/0471140864.ps1210s64 (2011)
126. Rillahan, C. D. &Paulson, J. C. Glycan microarrays for decoding the glycome. Annu. Rev. Biochem. 80, 797-823 (2011)
127. Smith, D. F. &Cummings, R. D. Application of microarrays for deciphering the structure and function of the human glycome. Mol. Cell Proteomics 12, 902-912 (2013)
128. Feizi, T. &Chai, W. G. Oligosaccharide microarrays to decipher the glyco code. Nat. Rev. Mol. Cell Biol. 5, 582-588 (2004)
129. Cummings, R. D. The repertoire of glycan determinants in the human glycome. Mol. BioSyst. 5, 1087-1104 (2009)
130. Day, C. J. et al. A direct-sensing galactose chemoreceptor recently evolved in invasive strains of Campylobacter jejuni. Nat. Commun. 7, 13206 (2016)
131. McGuckin, M. A., Linden, S. K., Sutton, P. &Florin, T. H. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9, 265-278 (2011)
132. Kilcoyne, M. et al. Construction of a natural mucin microarray and interrogation for biologically relevant glyco-epitopes. Anal. Chem. 84, 3330-3338 (2012)
133. Brown, A. &Higgins, M. K. Carbohydrate binding molecules in malaria pathology. Curr. Opin. Struct. Biol. 20, 560-566 (2010)
134. Zhao, H., Yang, Y., von Itzstein, M. &Zhou, Y. Carbohydrate-binding protein identification by coupling structural similarity searching with binding affinity prediction. J. Comput. Chem. 35, 2177-2183 (2014)
135. Yang, Y., Zhan, J., Zhao, H. &Zhou, Y. A new size-independent score for pairwise protein structure alignment and its application to structure classification and nucleic-acid binding prediction. Proteins 80, 2080-2088 (2012)
136. Taherzadeh, G., Zhou, Y., Liew, A. W. &Yang, Y. Sequence-based prediction of protein-carbohydrate binding sites using support vector machines. J. Chem. Inf. Model. 56, 2115-2122 (2016)
137. Spillmann, D. &Burger, M. M. Carbohydratecarbohydrate interactions in adhesion. J. Cell. Biochem. 61, 562-568 (1996)
138. Varki, A. Selectin ligands. Proc. Natl Acad. Sci. USA 91, 7390-7397 (1994)
139. Moran, A. P., Gupta, A. &Joshi, L. Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 60, 1412-1425 (2011)
140. Popescu, O., Checiu, I., Gherghel, P., Simon, Z. &Misevic, G. N. Quantitative and qualitative approach of glycan-glycan interactions in marine sponges. Biochimie 85, 181-188 (2003)
141. Bucior, I., Scheuring, S., Engel, A. &Burger, M. M. Carbohydrate-carbohydrate interaction provides adhesion force and specificity for cellular recognition. J. Cell Biol. 165, 529-537 (2004)
142. Humphreys, T. Chemical dissolution and in vitro reconstruction of sponge cell adhesions: I. Isolation and functional demonstration of the components involved. Dev. Biol. 8, 27-47 (1963)
143. Handa, K. et al. Le(x) glycan mediates homotypic adhesion of embryonal cells independently from E-cadherin: a preliminary note. Biochem. Biophys. Res. Commun. 358, 247-252 (2007)
144. Iwabuchi, K., Yamamura, S., Prinetti, A., Handa, K. &Hakomori, S. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J. Biol. Chem. 273, 9130-9138 (1998)
145. Kojima, N. &Hakomori, S. Specific interaction between gangliotriaosylceramide (Gg3) and sialosyllactosylceramide (GM3) as a basis for specific cellular recognition between lymphoma and melanoma cells. J. Biol. Chem. 264, 20159-20162 (1989)
146. Sava, I. G. et al. Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells. J. Biol. Chem. 284, 18194-18201 (2009)
147. Giuliani, M. M. et al. A universal vaccine for serogroup B meningococcus. Proc. Natl Acad. Sci. USA 103, 10834-10839 (2006)
148. Jasti, A. K. et al. Guillain-Barre syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev. Clin. Immunol. 12, 1175-1189 (2016)
149. Cunningham, M. W. in Streptococcus pyogenes: Basic Biology to Clinical Manifestations (eds Ferretti, J. J., Stevens, D. L. &Fischetti, V.A) (University of Oklahoma Health Sciences Center Library, 2016)
150. Machado Ribeiro, F. &Goldenberg, T. Mycobacteria and autoimmunity. Lupus 24, 374-381 (2015)
151. Radic, M. Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases. World J. Gastroenterol. 20, 12839-12846 (2014)
152. Janssen, R. et al. Host-pathogen interactions in Campylobacter infections: the host perspective. Clin. Microbiol. Rev. 21, 505-518 (2008)
153. Monzavi-Karbassi, B., Cunto-Amesty, G., Luo, P. &Kieber-Emmons, T. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol. 20, 207-214 (2002)
154. Kiseleva, E. P. et al. Isolation and structural identification of glycopolymers of Bifidobacterium bifidum BIM B-733D as putative players in pathogenesis of autoimmune thyroid diseases. Benef. Microbes 4, 375-391 (2013)
155. Mazmanian, S. K., Round, J. L. &Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625 (2008)
156. Arike, L., Holmen-Larsson, J. &Hansson, G. C. Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases. Glycobiology 27, 318-328 (2017)
157. Pickard, J. M., Zeng, M. Y., Caruso, R. &Nunez, G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279, 70-89 (2017)
158. Umesaki, Y., Tohyama, K. &Mutai, M. Appearance of fucolipid after conventionalization of germ-free mice. J. Biochem. 90, 559-561 (1981)
159. Merry, C. L. R., Lyon, M., Deakin, J. A., Hopwood, J. J. &Gallagher, J. T. Highly sensitive sequencing of the sulfated domains of heparan sulfate. J. Biol. Chem. 274, 18455-18462 (1999)
160. Wuhrer, M. Glycomics using mass spectrometry. Glycoconj. J. 30, 11-22 (2013)
161. Taylor, M. E. &Drickamer, K. Introduction to glycobiology (Oxford Univ. Press, 2011)
162. Zaia, J. Mass spectrometry and glycomics. OMICS 14, 401-418 (2010)
163. Hinneburg, H. et al. Distinguishing N-acetylneuraminic acid linkage isomers on glycopeptides by ion mobilitymass spectrometry. Chem. Commun. 52, 4381-4384 (2016)
164. Gustafsson, O. J. et al. MALDI imaging mass spectrometry of N-linked glycans on formalin-fixed paraffin-embedded murine kidney. Anal. Bioanal Chem. 407, 2127-2139 (2015)
165. Nours, J. et al. Structural basis of subtilase cytotoxin SubAB assembly. J. Biol. Chem. 288, 27505-27516 (2013)